Association of GLP-1 receptor agonists with alcohol use disorder-related and substance use disorder-related hospital admissions during treatment and after discontinuation: a Swedish register-based within-individual observational study

2026/07/16 by Patrick Bach, Johan Franck, Jonas Hällgren +5 · 1 voice
Medicine · #Diabetes Treatment and Management #Diabetes, Cardiovascular Risks, and Lipoproteins #Substance Abuse Treatment and Outcomes

paper · doi:10.1016/s2215-0366(26)00172-0

openalex publication_date 2026/07/16 · crossref created 2026/07/16 · crossref deposited 2026/07/16 · crossref indexed 2026/07/16 · openalex created_date 2026/07/17 · openalex updated_date 2026/07/22 · crossref issued 2026/08/01 · crossref published 2026/08/01 · crossref published-print 2026/08/01

Citations

• Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Discussions

• It would be great to get a larger study to be able to stratify the post-discontinuation results based on the length of GLP1 exposure and the severity of AUD/SUD. doi.org/10.1016/S22... [bsky, 0 points, 0 comments]